NCT07096609 2026-04-03
LONGIST
Asan Medical Center
Phase 1/2 Recruiting
Clinical Trials
11 trialsNCT06640361 2024-12-27
A Study of Olverembatinib in SDH-deficient GIST.
Ascentage Pharma Group Inc.
Phase 3 Recruiting
NCT04599660 2024-02-01
RetroGIST
Italian Sarcoma Group
Completed
NCT05895942 2023-06-09
EMMBKM
Xijing Hospital
Unknown
NCT04761172 2021-02-18
NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours
Leiden University Medical Center
Phase 2/3 Unknown
NCT03862885 2020-07-27
Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST
Blueprint Medicines Corporation
Approved for marketing
NCT02015065 2020-03-30
Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03082079 2017-05-16
Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT01323400 2016-02-25
PAZOGIST
Centre Leon Berard
Phase 2 Completed
NCT00618319 2015-10-02
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
Biogen
Phase 2 Completed
NCT01459757 2013-06-19
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
Pfizer
Completed